Biosimilar User Fee Agreement Puts FDA On Hook For Delayed Guidances

 
• By Sue Sutter
  
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards